Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C22H28N2O |
| Molecular Weight | 336.4705 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)N2CCC(CC2)N(C(C)=O)C3=CC=CC=C3
InChI
InChIKey=OKTLVZBUKMRPLL-UHFFFAOYSA-N
InChI=1S/C22H28N2O/c1-18(17-20-9-5-3-6-10-20)23-15-13-22(14-16-23)24(19(2)25)21-11-7-4-8-12-21/h3-12,18,22H,13-17H2,1-2H3
| Molecular Formula | C22H28N2O |
| Molecular Weight | 336.4705 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:55:47 GMT 2023
by
admin
on
Sat Dec 16 09:55:47 GMT 2023
|
| Record UNII |
0O1GKW2BQO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9815
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
||
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
101860-00-8
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | |||
|
0O1GKW2BQO
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | |||
|
62307
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | |||
|
ACETYL-.ALPHA.-METHYLFENTANYL
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | |||
|
DTXSID90869365
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | |||
|
.ALPHA.-METHYLACETYLFENTANYL
Created by
admin on Sat Dec 16 09:55:47 GMT 2023 , Edited by admin on Sat Dec 16 09:55:47 GMT 2023
|
PRIMARY | .ALPHA.-Methylacetylfentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. .ALPHA.-Methylacetylfentanyl is made with the same synthetic route as .ALPHA.-methylfentanyl, but by substituting the relatively common acetic anhydride for the more difficult to obtain chemical propionic anhydride in the synthesis. .ALPHA.-Methylacetylfentanyl has similar effects to fentanyl. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
BINDING
Ki
|
||
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
ED50-PO(mg/kg) = 0.106, LD50-PO(mg/kg) = 125, Potency ratio to morphine = 3.1, Potency ratio to fentanyl = 0.06
|
